drugset / Trial / NCT03010579
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an randomized trial to evaluate the potential benefit of erythropoietin in the treatment of anemia in patients with lymphoma after autologous hematopoietic stem cell transplantation.
Timeline
- Start
- 2016-10
- Primary completion
- 2017-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 10000 iu | Subcutaneous |
| Comparator | B12 | Other / unclassified | — | Oral |
| Comparator | Ferrous Sulfate | Diagnostic / imaging agent | — | Oral |
| Comparator | folic acid | Other / unclassified | — | Oral |